$AVXL News Article - Anavex Life Sciences Announce
Post# of 26719
(Total Views: 70)
Posted On: 10/17/2022 10:06:07 AM
$AVXL News Article - Anavex Life Sciences Announces Late-Breaking Presentation of Phase 2b/3 Data of Oral ANAVEX 2-73 (blarcamesine) for Early Alzheimer's Disease at the Upcoming Clinical Trials on Alzheimer's Disease (CTAD) Congress 2022 https://marketwirenews.com/news-releases/anav...35140.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼